摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-methoxy-5,5-dioxo-6,6a-dihydrodipyrido[2,1-c:4',3'-e][1,2,4]thiadiazin-7-yl sulfonamide | 1335122-23-0

中文名称
——
中文别名
——
英文名称
8-methoxy-5,5-dioxo-6,6a-dihydrodipyrido[2,1-c:4',3'-e][1,2,4]thiadiazin-7-yl sulfonamide
英文别名
3-Methoxy-4a,6-dioxopyrido[1',2':4,3]pyrido[4,3-e][1,2,4]thiadiazine-4-sulfonamide;12-methoxy-8,8-dioxo-8λ6-thia-1,5,9-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5,11,13-pentaene-11-sulfonamide
8-methoxy-5,5-dioxo-6,6a-dihydrodipyrido[2,1-c:4',3'-e][1,2,4]thiadiazin-7-yl sulfonamide化学式
CAS
1335122-23-0
化学式
C11H12N4O5S2
mdl
——
分子量
344.372
InChiKey
ZTDXINULRDONTE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.4
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    148
  • 氢给体数:
    2
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    甲醇4-氯吡啶-3-磺酰胺尿素 、 sodium hydroxide 作用下, 以 为溶剂, 反应 5.0h, 以66%的产率得到8-methoxy-5,5-dioxo-6,6a-dihydrodipyrido[2,1-c:4',3'-e][1,2,4]thiadiazin-7-yl sulfonamide
    参考文献:
    名称:
    Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives
    摘要:
    A series of novel 3-pyridinesulfonamide derivatives (2-5, 9-11 and 13-15) have been synthesized and investigated as inhibitors of five isoforms of zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), that is, the cytosolic ubiquitous CA I and II, and isozymes CA IX and XII (cancer-associated), and XIV. Against the human isozyme hCA I the new compounds showed K(I)s in the range of 0.089-251 mu M, whereas toward hCA II, K(I)s = 50.5-487 nM. Isozyme hCA IX was inhibited with K(I)s in the range of 5.2-18.3 nM, while hCA XII with K(I)s = 6.0-16.4 nM, and hCA XIV with K(I)s = 76.4-152.0 nM. All of the new compounds 2-5,9-11 and 13-15 showed excellent hCA IX inhibitory efficacy, with Kis = 5.2-18.3 nM, being much more effective as compared to the clinically used AAZ, MZA, EZA, DCP and IND (K(I)s = 24-50 nM). (C) 2011 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2011.07.011
点击查看最新优质反应信息

文献信息

  • Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives
    作者:Zdzisław Brzozowski、Jarosław Sławiński、Maria Gdaniec、Alessio Innocenti、Claudiu T. Supuran
    DOI:10.1016/j.ejmech.2011.07.011
    日期:2011.9
    A series of novel 3-pyridinesulfonamide derivatives (2-5, 9-11 and 13-15) have been synthesized and investigated as inhibitors of five isoforms of zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), that is, the cytosolic ubiquitous CA I and II, and isozymes CA IX and XII (cancer-associated), and XIV. Against the human isozyme hCA I the new compounds showed K(I)s in the range of 0.089-251 mu M, whereas toward hCA II, K(I)s = 50.5-487 nM. Isozyme hCA IX was inhibited with K(I)s in the range of 5.2-18.3 nM, while hCA XII with K(I)s = 6.0-16.4 nM, and hCA XIV with K(I)s = 76.4-152.0 nM. All of the new compounds 2-5,9-11 and 13-15 showed excellent hCA IX inhibitory efficacy, with Kis = 5.2-18.3 nM, being much more effective as compared to the clinically used AAZ, MZA, EZA, DCP and IND (K(I)s = 24-50 nM). (C) 2011 Elsevier Masson SAS. All rights reserved.
查看更多